Company Lonza Group AG OTC Markets

Equities

LZAGY

US54338V1017

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for Lonza Group AG

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 15:59:30 2024-06-14 EDT			5-day change	1st Jan Change
53.75 ^USD	-0.20%		-3.17%	+27.70%

05-14	Swiss Market Index Edges Up Ahead of Inflation Report	MT
05-14	Global markets live: Apple, Sony, Vodafone, Booking, Walmart...

Lonza Group AG is one of the world leaders of the development, production and marketing of chemical products. Net sales break down by family of products and services as follows:

- bio-pharmaceuticals (52.6%): exclusive syntheses, microbiological fermentation products , mammalian cell cultures, etc.;

- capsules and dosing solutions for biopharmaceuticals, drugs and nutrition products (20.3%). In addition, the group offers nutritional ingredients;

- small molecule drug substances (13.2%);

- technologies and platforms for manufacturing processes and production of cell and gene therapies (11.1%);

- other (2.8%).

Net sales are distributed geographically as follows: Switzerland (16%), Europe (29.8%), the United States (38.8%), the Americas (3%), Japan (3.7%), China (2.6%), Asia (5.8%) and other (0.3%).

Number of employees: 18,000

CHF in Million	2022	Weight	2023	Weight	Delta
Biologics 55.4 %	3,274	52.6 %	3,719	55.4 %	+13.59%
Capsules & Health Ingredients 17.3 %	1,266	20.3 %	1,161	17.3 %	-8.29%
Small Molecules 13.4 %	819	13.2 %	901	13.4 %	+10.01%
Cell & Gene 10.4 %	693	11.1 %	696	10.4 %	+0.43%
Corporate/Eliminations 3.6 %	171	2.7 %	240	3.6 %	+40.35%

CHF in Million	2022	Weight	2023	Weight	Delta
United States 31.8 %	2,415	38.8 %	2,136	31.8 %	-11.55%
Switzerland 17.4 %	996	16.0 %	1,168	17.4 %	+17.27%
Japan 8.1 %	227	3.6 %	544	8.1 %	+139.65%
Ireland 5.5 %	343	5.5 %	368	5.5 %	+7.29%
Belgium 5.1 %	302	4.9 %	341	5.1 %	+12.91%
Denmark 4.8 %	158	2.5 %	322	4.8 %	+103.80%
Germany 4.5 %	224	3.6 %	302	4.5 %	+34.82%
Rest of Europe 2.9 %	207	3.3 %	195	2.9 %	-5.80%
China 2.6 %	161	2.6 %	172	2.6 %	+6.83%
United Kingdom 2.5 %	139	2.2 %	171	2.5 %	+23.02%
Singapore 2.0 %	113	1.8 %	137	2.0 %	+21.24%
Sweden 1.8 %	143	2.3 %	123	1.8 %	-13.99%
France 1.7 %	116	1.9 %	111	1.7 %	-4.31%
South Korea 1.4 %	141	2.3 %	97	1.4 %	-31.21%
Canada 1.3 %	63	1.0 %	90	1.3 %	+42.86%
Netherlands 1.3 %	132	2.1 %	88	1.3 %	-33.33%
Brazil 1.1 %	49	0.8 %	71	1.1 %	+44.90%
Italy 0.8 %	41	0.7 %	52	0.8 %	+26.83%
India 0.6 %	42	0.7 %	42	0.6 %	0.00%
Spain 0.6 %	41	0.7 %	40	0.6 %	-2.44%
Mexico 0.5 %	34	0.5 %	33	0.5 %	-2.94%
Rest of Asia 0.4 %	36	0.6 %	29	0.4 %	-19.44%
Rest of Latin America 0.4 %	38	0.6 %	26	0.4 %	-31.58%
Australia & New Zealand 0.2 %	21	0.3 %	16	0.2 %	-23.81%
Thailand 0.2 %	15	0.2 %	15	0.2 %	0.00%
Indonesia 0.2 %	16	0.3 %	14	0.2 %	-12.50%
Czech Republic 0.2 %	7	0.1 %	11	0.2 %	+57.14%
Other Countries 0.0 %	2	0.0 %	2	0.0 %	0.00%
Rest of North and Central America 0.0 %	1	0.0 %	1	0.0 %	0.00%

Managers	Title	Age	Since
Albert Baehny CEO	Chief Executive Officer	72	17-04-24
Philippe Deecke DFI	Director of Finance/CFO	52	21-11-30
Maria Nunez COO	Chief Operating Officer	55	22-07-31
Lyle Wheeler IRC	Investor Relations Contact	-	-

Members of the board	Title	Age	Since
Barbara Richmond BRD	Director/Board Member	63	14-04-15
Jürgen B. Steinemann BRD	Director/Board Member	66	14-04-15
Marion Helmes BRD	Director/Board Member	58	22-05-04
Albert Baehny CEO	Chief Executive Officer	72	17-04-24
Christoph Mäder BRD	Director/Board Member	64	16-04-25
Roger Nitsch BRD	Director/Board Member	63	22-04-30
Angelica Kohlmann BRD	Director/Board Member	64	18-05-03
Olivier Verscheure BRD	Director/Board Member	52	18-05-03

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	74,468,752	72,076,913 ( 96.79 %)	2,352,163 ( 3.159 %)	96.79 %

Name	Equities	%	Valuation
LONZA GROUP AG 3.159 %	2,352,163	3.159 %	1 268 M $
Norges Bank Investment Management 2.990 %	2,226,615	2.990 %	1 200 M $
Carmignac Gestion Luxembourg SA (UK) 0.3586 %	267,011	0.3586 %	144 M $
Seilern Investment Management Ltd. 0.2465 %	183,557	0.2465 %	99 M $
Caixabank Asset Management SGIIC SA 0.2218 %	165,186	0.2218 %	89 M $
Eurizon Capital SGR SpA 0.1992 %	148,372	0.1992 %	80 M $
Union Bancaire Privée, UBP SA 0.1937 %	144,255	0.1937 %	78 M $
Crédit Mutuel Asset Management SA 0.1921 %	143,064	0.1921 %	77 M $
CAPFI DELEN Asset Management NV 0.1732 %	128,948	0.1732 %	70 M $
Rathbones Asset Management Ltd. 0.1669 %	124,272	0.1669 %	67 M $

Name	Equities	%	Valuation
SBI Funds Management Ltd. 0.4999 %	3,723,000	0.4999 %	201 M $
Vigilant Capital Management LLC (Old) 0.0323 %	240,842	0.0323 %	13 M $
Zevin Asset Management LLC 0.0165 %	123,110	0.0165 %	7 M $
Torray Investment Partners LLC 0.0147 %	109,698	0.0147 %	6 M $
Madison Asset Management LLC 0.008090 %	60,246	0.008090 %	3 M $
Domini Impact Investments LLC 0.003384 %	25,200	0.003384 %	1 M $
RhumbLine Advisers LP 0.001861 %	13,855	0.001861 %	747 006 $
SkyView Investment Advisors LLC 0.001081 %	8,048	0.001081 %	433 916 $
Henry James International Management, Inc. 0.000996 %	7,420	0.000996 %	400 057 $
GAMMA Investing LLC 0.000120 %	891	0.000120 %	48 039 $

Name	Equities	%	Valuation
LONZA GROUP AG 3.16%	2,352,163	3.16%	1,268,183,853 $

Lonza Group AG

Muenchensteinerstrasse 38

4002, Basel

+41 61 316 81 11

http://www.lonza.com

Name	Category and Sector
Arch Protection Chemicals Pvt Ltd. Arch Protection Chemicals Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Lonza Group AG, Arch Protection Chemicals Pvt Ltd. is an Indian company that provides business services. The company is based in Mumbai, India.	Miscellaneous Commercial Services
Arch UK Biocides Ltd. Arch UK Biocides Ltd. Household/Personal CareConsumer Non-Durables Part of Lonza Group AG, Arch UK Biocides Ltd. is a provider of integrated healthcare solutions to the pharmaceutical, biotech, and specialty ingredients markets. The company is based in Castleford, UK, and offers careers in various disciplines such as bioengineering and chemistry. Lonza optimizes scientific innovation and manufacturing technology to enable its customers to serve their patients and consumers. Lonza's quality management is committed to meeting all specifications and fulfilling customer needs and expectations. Founded in 2003, the British company's solutions aim to improve life quality by preventing illness, enabling healthier lifestyles, and supporting a safe environment.	Household/Personal Care
Capsugel Italy SRL Capsugel Italy SRL Miscellaneous Commercial ServicesCommercial Services Part of Chester Investor Holdings SRL, Capsugel Italy SRL provides management consulting services. The company is based in Milan, Italy.	Miscellaneous Commercial Services
Hickson Ltd. Hickson Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 1937, Hickson Ltd. is a business consulting British company that provides consulting services. The company is based in Castleford, UK and is part of Lonza Group AG.	Miscellaneous Commercial Services
Capsugel Hungary Kft
Innovative Water Care Europe SAS Innovative Water Care Europe SAS Specialty StoresRetail Trade Innovative Water Care Europe SAS manufactures basic organic chemicals. The company was founded on September 17, 1982 and is headquartered in Amboise, France.	Specialty Stores
Capsugel France SAS Capsugel France SAS Apparel/Footwear RetailRetail Trade Capsugel France SAS manufactures & distributes clothes and clothing accessories. The company was founded in 1970 and is headquartered in Colmar, France.	Apparel/Footwear Retail
Capsugel Financeco SCA Capsugel Financeco SCA Pharmaceuticals: MajorHealth Technology Part of Lonza Group AG, Capsugel Financeco SCA is a Luxembourger pharmaceutical company founded in 2011. The company manufactures pharmaceutical products and is based in Luxembourg, Luxembourg.	Pharmaceuticals: Major
Capsugel Germany GmbH
Capsugel Healthcare Pvt Ltd.
Lonza India Pvt Ltd.
Lonza Sales AG Lonza Sales AG Medical DistributorsDistribution Services Part of Lonza Group AG, Lonza Sales AG supplies pharmaceutical, biotech and specialty ingredients. The company is based in Basel, Switzerland.	Medical Distributors
Lonza Finance International NV Lonza Finance International NV Finance/Rental/LeasingFinance Founded in 2019, Lonza Finance International NV is a financing subsidiary/special purpose entity that is part of Lonza Group AG. The company is based in Bornem, Belgium.	Finance/Rental/Leasing
Capsugel Belgium SA Capsugel Belgium SA Pharmaceuticals: MajorHealth Technology Capsugel Belgium NV provides dosage forms and solutions. The firm also sells equipment for filling empty and liquid capsules and equipment for sealing liquid capsules. The company was founded on October 1, 1961 and is headquartered in Bornem, Belgium.	Pharmaceuticals: Major
Lonza Swiss Finanz AG Lonza Swiss Finanz AG Finance/Rental/LeasingFinance Lonza Swiss Finanz AG engages in the provision of financing services within the companies of Lonza Group AG. It also invests in domestic and foreign industrial and commercial firms. The company was founded on December 23, 1974 and is headquartered in Basel, Switzerland.	Finance/Rental/Leasing
Capsugel Plöermel SASU Capsugel Plöermel SASU BiotechnologyHealth Technology Capsugel Plöermel SASU designs and manufactures biopharmaceuticals. The company is headquartered in Ploermel, France.	Biotechnology
Xcelience Clinical Services Ltd. Xcelience Clinical Services Ltd. Miscellaneous Commercial ServicesCommercial Services Part of MW Encap (Holdings) Ltd., Xcelience Clinical Services Ltd. provides packaging services. The company is based in London, UK.	Miscellaneous Commercial Services
Capsugel Spain SL Capsugel Spain SL Pharmaceuticals: MajorHealth Technology Part of Lonza Group AG, Capsugel Spain SL is a Spanish company that develops, promotes, and distributes empty gelified and polymer capsules. The company is based in Madrid, Spain.	Pharmaceuticals: Major
M.W. Encap Ltd. M.W. Encap Ltd. Pharmaceuticals: MajorHealth Technology Part of Lonza Group AG, M.W. Encap Ltd. is a British pharmaceutical company that manufactures drugs for pharmaceutical preparations. The company is based in London, UK. The company was founded in 1994. M.W. Encap was acquired by Capsugel, Inc. on March 01, 2013.	Pharmaceuticals: Major
Arch Timber Protection Arch Timber Protection Chemicals: SpecialtyProcess Industries Part of Lonza Group AG, Arch Timber Protection is a British company that manufactures inorganic basic chemicals. The company is located in UK.	Chemicals: Specialty
Capsugel Holdings SARL Capsugel Holdings SARL Specialty StoresRetail Trade Capsugel Holdings SARL operates as a pharmaceutical contract manufacturer and drug development company. The company is headquartered in Luxembourg, Luxembourg.	Specialty Stores
Arch Chemicals Ltd. Arch Chemicals Ltd. Chemicals: SpecialtyProcess Industries Arch Chemicals Ltd. engages in the manufacture of inorganic basic chemicals. Its products are mainly used in the swimming pool for body treatment. The company was founded on February 24, 1978 and is headquartered in Castleford, the United Kingdom.	Chemicals: Specialty
Capsugel FinanceCo II SARL Capsugel FinanceCo II SARL Pharmaceuticals: MajorHealth Technology Part of Lonza Group AG, Capsugel FinanceCo II SARL is a company based in Luxembourg, Luxembourg.	Pharmaceuticals: Major
Capsugel FinanceCo SARL
Lonza Biologics Plc Lonza Biologics Plc Miscellaneous Commercial ServicesCommercial Services Lonza Biologics Plc manufactures monoclonal antibodies, recombinant proteins and diagnostic monoclonal antibodies. The company was founded in 1897 and is headquartered in Slough, the United Kingdom.	Miscellaneous Commercial Services
Capsugel Holdings US, Inc. Capsugel Holdings US, Inc. Pharmaceuticals: MajorHealth Technology Capsugel Holdings US, Inc. develops dosage forms and solutions for the healthcare industry around the world. It offers gelatin, alternate polymer, and liquid-filled capsules; hard gelatin, sprinkle, plus HPMC, fish gelatin, pearlescent, over-encapsulation, pre-clinical, liquid, soft gelatin, acid-resistant capsules; gelcaps; capsule in capsule technology products; and solid lipid pellet technology products. The firm also provides precision powder micro-dosing systems, CFS liquid filling and sealing machines, profill manual capsule filling machines, and commercial scale capsule filling machines. The company was founded in 1963 and is headquartered in Morristown, NJ.	Pharmaceuticals: Major
Capsugel France Holdings SAS Capsugel France Holdings SAS Pharmaceuticals: MajorHealth Technology Part of Lonza Group AG, Capsugel France Holdings SAS is a trusted partner in innovative capsules, dosage form solutions and health ingredients for pharmaceutical and nutraceutical companies. The company is based in Colmar, France. Capsugel France Holdings offers a range of hard gelatin, HPMC or alternative polymer Capsugel® capsules to help bring improved pharmaceutical products to market faster.	Pharmaceuticals: Major
Arxada AG Arxada AG Chemicals: Major DiversifiedProcess Industries Arxada AG is a Swiss specialty chemicals company that offers consumer microbial control, industrial microbial control, and specialty product solutions. The company is based in Basel, CH, and has subsidiaries in the Netherlands, United States, and Thailand. The company provides a wide range of differentiated products for various end markets, including hygiene, home and personal care, wood protection, crop protection, and food, beverage, and water. Arxada has leading regulatory capabilities, IP expertise, and an established track record in the industry. C. Marc Doyle has been the CEO of the company since 2021.	Chemicals: Major Diversified

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

480.3 CHF

Average target price

583.7 CHF

Spread / Average Target

+21.53%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+40.80%	53.67B
IQVIA HOLDINGS INC.	-8.05%	38.76B
CELLTRION, INC.	-8.98%	27.27B
ICON PUBLIC LIMITED COMPANY	+10.69%	25.91B
ALNYLAM PHARMACEUTICALS, INC.	-16.21%	20.29B
UNITED THERAPEUTICS CORPORATION	+31.00%	12.78B
MEDPACE HOLDINGS, INC.	+28.51%	12.18B
BIO-TECHNE CORPORATION	-1.67%	11.96B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-11.39%	10.79B

Other Biotechnology & Medical Research